» Articles » PMID: 32181567

CXCR4-SF1 Bifunctional Adipose-derived Stem Cells Benefit for the Treatment of Leydig Cell Dysfunction-related Diseases

Overview
Journal J Cell Mol Med
Date 2020 Mar 18
PMID 32181567
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell transplantation is a candidate method for the treatment of Leydig cell dysfunction-related diseases. However, there are still many problems that limit its clinical application. Here, we report the establishment of CXCR4-SF1 bifunctional adipose-derived stem cells (CXCR4-SF1-ADSCs) and their reparative effect on Leydig cell dysfunction. CD29 CD44 CD34 CD45 ADSCs were isolated from adipose tissue and purified by fluorescence-activated cell sorting (FACS). Infection with lentiviruses carrying the CXCR4 and SF1 genes was applied to construct CXCR4-SF1-ADSCs. The CXCR4-SF1-ADSCs exhibited enhanced migration and had the ability to differentiate into Leydig-like cells in vitro. Furthermore, the bifunctional ADSCs were injected into BPA-mediated Leydig cell damage model mice via the tail vein. We found that the CXCR4-SF1-ADSCs were capable of homing to the injured testes, differentiating into Leydig-like cells and repairing the deficiency in reproductive function caused by Leydig cell dysfunction. Moreover, we investigated the mechanism underlying SF1-mediated differentiation and testosterone synthesis in Leydig cells, and the B-box and SPRY Domain Containing Protein (BSPRY) gene was proposed to be involved in this process. This study provides insight into the treatment of Leydig cell dysfunction-related diseases.

Citing Articles

Microenvironment of spermatogonial stem cells: a key factor in the regulation of spermatogenesis.

Liu W, Du L, Li J, He Y, Tang M Stem Cell Res Ther. 2024; 15(1):294.

PMID: 39256786 PMC: 11389459. DOI: 10.1186/s13287-024-03893-z.


Is It Possible to Treat Infertility with Stem Cells?.

Petric P, Vrtacnik-Bokal E, Stimpfel M Reprod Sci. 2021; 28(6):1733-1745.

PMID: 33834375 DOI: 10.1007/s43032-021-00566-7.


CXCR4-SF1 bifunctional adipose-derived stem cells benefit for the treatment of Leydig cell dysfunction-related diseases.

Li X, Xu A, Li K, Zhang J, Li Q, Zhao G J Cell Mol Med. 2020; 24(8):4633-4645.

PMID: 32181567 PMC: 7176872. DOI: 10.1111/jcmm.15128.

References
1.
Klotz L . Testosterone therapy and prostate cancer--safety concerns are well founded. Nat Rev Urol. 2015; 12(1):48-54. DOI: 10.1038/nrurol.2014.338. View

2.
Yazawa T, Mizutani T, Yamada K, Kawata H, Sekiguchi T, Yoshino M . Differentiation of adult stem cells derived from bone marrow stroma into Leydig or adrenocortical cells. Endocrinology. 2006; 147(9):4104-11. DOI: 10.1210/en.2006-0162. View

3.
Schimmer B, White P . Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol. 2010; 24(7):1322-37. PMC: 5417463. DOI: 10.1210/me.2009-0519. View

4.
Zhang J, Liu G, Ruan Y, Wang J, Zhao K, Wan Y . Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency. Nat Commun. 2014; 5:5042. PMC: 4205889. DOI: 10.1038/ncomms6042. View

5.
Savchuk I, Soder O, Svechnikov K . Mouse leydig cells with different androgen production potential are resistant to estrogenic stimuli but responsive to bisphenol a which attenuates testosterone metabolism. PLoS One. 2013; 8(8):e71722. PMC: 3744456. DOI: 10.1371/journal.pone.0071722. View